MURPHY ANDREW J — SEC insider filings
SEC reporting owner CIK 1796226. 28 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers all 28 filings on record, filed 2020-10-23 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 207 legs across 13 filings — 69,565 shares, $53,938,489 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 75.
- Largest priced transaction: sale of 1,881 shares @ $817.36 ($1,537,454) in REGENERON PHARMACEUTICALS, INC., filed 2023-12-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | 28 | — | 207 legs · 69,565 sh · $53,938,489 | 75 |
Insider filings — MURPHY ANDREW J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 17,000 @ $381.92 · Tax withholding (F): 11,989 @ $960.02 · Sale (S): 93 @ $949.69 · Sale (S): 74 @ $950.61 · Sale (S): 298 @ $951.75 · Sale (S): 220 @ $952.75 · +13 more | EDGAR |
| 2026-11-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Gift (G): 1,054 @ $0 | EDGAR |
| 2026-10-15 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 17,000 @ $381.92 · Tax withholding (F): 12,853 @ $754.58 · Sale (S): 6 @ $753.76 · Sale (S): 35 @ $755.91 · Sale (S): 16 @ $757.68 · Sale (S): 24 @ $758.16 · +24 more | EDGAR |
| 2025-12-11 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 4,229 @ $701.51 | EDGAR |
| 2025-12-09 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 3,715 @ $0 · Tax withholding (F): 1,699 @ $712.94 · Grant/award (A): 18,315 (derivative) @ $0 | EDGAR |
| 2025-10-31 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 35,000 @ $555.67 · Tax withholding (F): 32,490 @ $648.82 · Gift (G): 1,538 @ $0 · Option exercise (M): 35,000 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 1,054 @ $730.81 | EDGAR |
| 2024-12-10 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 3,499 @ $0 · Tax withholding (F): 492 @ $787 · Grant/award (A): 13,472 (derivative) @ $0 | EDGAR |
| 2024-11-12 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Gift (G): 1,185 @ $0 | EDGAR |
| 2024-08-15 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 20,000 @ $399.66 · Tax withholding (F): 13,637 @ $1,141.49 · Sale (S): 55 @ $1,140.31 · Sale (S): 48 @ $1,142.94 · Sale (S): 79 @ $1,143.28 · Sale (S): 45 @ $1,144.89 · +15 more | EDGAR |
| 2024-03-15 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 20,000 @ $399.66 · Tax withholding (F): 14,217 @ $971.82 · Sale (S): 182 @ $951.92 · Sale (S): 444 @ $952.40 · Sale (S): 576 @ $953.77 · Sale (S): 870 @ $954.66 · +11 more | EDGAR |
| 2023-12-14 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 7,657 @ $856.71 | EDGAR |
| 2023-12-12 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 883 @ $843.79 · Grant/award (A): 3,199 @ $0 · Tax withholding (F): 5,105 @ $844.09 · Tax withholding (F): 669 @ $844.09 · Grant/award (A): 11,473 (derivative) @ $0 | EDGAR |
| 2023-12-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 20,000 @ $270.43 · Tax withholding (F): 13,464 @ $813.58 · Sale (S): 136 @ $810.38 · Sale (S): 103 @ $811.37 · Sale (S): 372 @ $812.57 · Sale (S): 167 @ $813.66 · +9 more | EDGAR |
| 2023-11-15 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 20,000 @ $270.43 · Tax withholding (F): 13,508 @ $795.69 · Sale (S): 752 @ $794.57 · Sale (S): 347 @ $795.38 · Sale (S): 204 @ $797.79 · Sale (S): 1,614 @ $798.63 · +8 more | EDGAR |
| 2023-05-10 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Gift (G): 1,326 @ $0 | EDGAR |
| 2022-12-20 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 4,129 @ $0 · Grant/award (A): 15,238 (derivative) @ $0 | EDGAR |
| 2022-12-13 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 492 @ $753.28 | EDGAR |
| 2022-11-16 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Gift (G): 1,360 @ $0 · Option exercise (M): 10,000 @ $179.13 · Tax withholding (F): 6,280 @ $746 · Sale (S): 109 @ $718.60 · Sale (S): 336 @ $719.62 · Sale (S): 3 @ $720.26 · +18 more | EDGAR |
| 2022-08-17 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 10,000 @ $179.13 · Tax withholding (F): 6,487 @ $634.25 · Sale (S): 76 @ $639.85 · Sale (S): 148 @ $640.91 · Sale (S): 537 @ $641.47 · Sale (S): 329 @ $642.53 · +8 more | EDGAR |
| 2022-05-18 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 10,000 @ $179.13 · Tax withholding (F): 6,457 @ $648.31 · Sale (S): 59 @ $655.40 · Sale (S): 58 @ $656.52 · Sale (S): 60 @ $657.51 · Sale (S): 123 @ $658.56 · +12 more | EDGAR |
| 2022-02-16 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 10,000 @ $179.13 · Tax withholding (F): 6,460 @ $626.79 · Sale (S): 99 @ $622.09 · Sale (S): 50 @ $625.90 · Sale (S): 421 @ $626.51 · Sale (S): 630 @ $627.49 · +8 more | EDGAR |
| 2021-12-14 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 697 @ $664.34 | EDGAR |
| 2021-12-10 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 3,462 @ $0 · Option exercise (M): 16,500 @ $52.03 · Tax withholding (F): 9,378 @ $657.11 · Sale (S): 399 @ $657.61 · Sale (S): 330 @ $658.78 · Sale (S): 370 @ $659.29 · +15 more | EDGAR |
| 2021-11-17 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Gift (G): 1,645 @ $0 · Option exercise (M): 16,579 @ $52.03 · Tax withholding (F): 9,412 @ $641.50 · Sale (S): 465 @ $642.76 · Sale (S): 924 @ $643.42 · Sale (S): 1,106 @ $644.71 · +15 more | EDGAR |
| 2020-12-11 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 8,285 @ $0 · Grant/award (A): 1,929 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2020-11-18 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 13,736 @ $30.63 · Tax withholding (F): 7,108 @ $561.39 · Sale (S): 743 @ $536.68 · Sale (S): 229 @ $537.38 · Sale (S): 591 @ $538.37 · Sale (S): 42 @ $539.87 · +16 more | EDGAR |
| 2020-10-23 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,921 @ $52.03 · Option exercise (M): 3,264 @ $30.63 · Option exercise (M): 3,264 (derivative) @ $0 · Option exercise (M): 1,921 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1796226 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs